Published on 29 Mar 2024 on GuruFocus.com via Yahoo Finance
Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercialization of cancer immunotherapies, has reported an insider sell according to the latest SEC filings. Chief Operating Officer Jennifer Jarrett sold 11,551 shares of the company on March 27, 2024. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.
The insider, Jennifer Jarrett, has been active in the market over the past year, selling a total of 196,515 shares and making no purchases of the company's stock during that period. The recent sell by the insider contributes to a pattern observed over the last year, where insider transactions for Arcus Biosciences Inc have consisted of 2 insider buys and 13 insider sells.